Mig-6 deficiency cooperates with oncogenic Kras to promote mouse lung tumorigenesis
- 1 October 2017
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 112, 47-56
Abstract
No abstract availableKeywords
Funding Information
- Intramural Research Program of the National Institute of Environmental Health Sciences Project (Z1AES103311-01)
- National Cancer Institute (U01CA105352)
This publication has 57 references indexed in Scilit:
- TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon CancersCell, 2012
- ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast CancerGenes & Cancer, 2011
- Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell linesExperimental Cell Research, 2011
- Mig-6 controls EGFR trafficking and suppresses gliomagenesisProceedings of the National Academy of Sciences, 2010
- Advances in Mucous Cell MetaplasiaAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial diseaseProceedings of the National Academy of Sciences, 2009
- Promotion of Lung Carcinogenesis by Chronic Obstructive Pulmonary Disease–Like Airway Inflammation in a K-ras–Induced Mouse ModelAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Oncogenic K-Ras Regulates Proliferation and Cell Junctions in Lung Epithelial Cells through Induction of Cyclooxygenase-2 and Activation of Metalloproteinase-9Molecular Biology of the Cell, 2009
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific GenesCancer Research, 2004